You are here

TruSight Oncology

Illumina Gets FDA Approval for Cancer Biomarker Test

Marketwatch

Tue, 08/27/24 - 11:14 am

TruSight Oncology

Illumina Obtains CDx Pan-Cancer Indication for TruSight Test

Medical Devices and Diagnostics Industry

Wed, 05/25/22 - 10:38 am

TruSight Oncology

companion diagnostics

Illumina Unveils Groundbreaking Comprehensive Genomic Profiling Test for Cancer in Europe

BioSpace

Tue, 03/15/22 - 10:45 am

TruSight Oncology